General MedicationsTOPICALGeneric
XOLEGEL
KETOCONAZOLE
Standard Dose
2%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview XOLEGEL is listed in Drugs@FDA under application 021946 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient KETOCONAZOLE Form and strength GEL;TOPICAL - 2% Sponsor INA PHARMS Submission history Latest submission status date: 2019-12-26 00:00:00.
Structured Monograph
Clinical summary
Approval overview XOLEGEL is listed in Drugs@FDA under application 021946 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient KETOCONAZOLE Form and strength GEL;TOPICAL - 2% Sponsor INA PHARMS Submission history Latest submission status date: 2019-12-26 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.